Probiotics in Clostridium difficile infection: reviewing the need for a multistrain probiotic
Open Access
- 1 March 2013
- journal article
- review article
- Published by Brill in Beneficial Microbes
- Vol. 4 (1), 39-51
- https://doi.org/10.3920/bm2012.0049
Abstract
In the past two years an enormous amount of molecular, genetic, metabolomic and mechanistic data on the host-bacterium interaction, a healthy gut microbiota and a possible role for probiotics in Clostridium difficile infection (CDI) has been accumulated. Also, new hypervirulent strains of C. difficile have emerged. Yet, clinical trials in CDI have been less promising than in antibiotic associated diarrhoea in general, with more meta-analysis than primary papers on CDI-clinical-trials. The fact that C. difficile is a spore former, producing at least three different toxins has not yet been incorporated in the rational design of probiotics for (recurrent) CDI. Here we postulate that the plethora of effects of C. difficile and the vast amount of data on the role of commensal gut residents and probiotics point towards a multistrain mixture of probiotics to reduce CDI, but also to limit (nosocomial) transmission and/or endogenous reinfection. On the basis of a retrospective chart review of a series of ten CDI patients where recurrence was expected, all patients on adjunctive probiotic therapy with multistrain cocktail (Ecologic®AAD/OMNiBiOTiC® 10) showed complete clinical resolution. This result, and recent success in faecal transplants in CDI treatment, are supportive for the rational design of multistrain probiotics for CDIKeywords
This publication has 54 references indexed in Scilit:
- The effects of commensal microbiota on immune cell subsets and inflammatory responsesImmunological Reviews, 2011
- Emerging molecular insights into the interaction between probiotics and the host intestinal mucosaNature Reviews Microbiology, 2011
- Health benefits of probiotics: are mixtures more effective than single strains?European Journal of Nutrition, 2011
- The emergence of ‘hypervirulence’ in Clostridium difficileInternational Journal of Medical Microbiology, 2010
- Biodiversity, ecological determinants, and metabolic exploitation of sourdough microbiotaFood Microbiology, 2009
- Alternative strategies for Clostridium difficile infectionInternational Journal of Antimicrobial Agents, 2009
- Toll-like receptors—novel targets in allergic airway disease (probiotics, friends and relatives)European Journal of Pharmacology, 2006
- Potent diarrheagenic mechanism mediated by the cooperative action of three enteropathogenic Escherichia coli -injected effector proteinsProceedings of the National Academy of Sciences of the United States of America, 2006
- Let's go mucosal: communication on slippery groundTrends in Immunology, 2004
- Sedimentation characteristics of noradrenergic vesicles from rat interscapular brown adipose tissueCanadian Journal of Physiology and Pharmacology, 1982